BRIEF-Hisamitsu Pharmaceutical's sales for March-May qtr seen down 8 pct - Nikkei
* Hisamitsu Pharmaceutical's group operating profit appears to have declined 13% on the year to just under 5 billion yen for March-May quarter - Nikkei
PARIS Feb 8 Sanofi, France's largest drugmaker, said it expected 2017 earnings per share to be stable or slightly lower after its fourth quarter results were affected by an increase in taxes and one-off charges.
The company had warned investors in 2015 not to expect any 'meaningful' profit growth for two years because of a downturn in its embattled diabetes division.
Sanofi said fourth-quarter business net income fell 2.9 percent at constant exchange rates to 1.61 billion euros ($1.7 billion). Total sales rose 3.4 percent to 8.87 billion euros.
Analysts polled by Reuters in partnership with Inquiry Financial had on average been expecting business net profit of 1.57 billion euros and net sales of 8.94 billion.
Sanofi said its fourth-quarter effective tax rate had reached 24 pct compared with 17.4 pct in 2015.
($1 = 0.9367 euros) (Reporting by Matthias Blamont and Matthieu Protard; Editing by Sudip Kar-Gupta)
* PRESENTS SUPPORTIVE DATA FROM ITS PHASE 3 STUDY IN SEVERE SYSTEMIC MASTOCYTOSIS Source text for Eikon: Further company coverage: (Gdynia Newsroom)